JJ PHARMA CONSULT ApS — Credit Rating and Financial Key Figures
CVR number: 33257635
Rosenørns Allé 16, 1634 København V
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -20.28 | -14.42 | -19.38 | -12.89 | -53.64 |
| Reduction in value of non-current assets | 93.48 | ||||
| EBIT | -20.28 | 79.06 | -19.38 | -12.89 | -53.64 |
| Other financial income | 1.13 | 0.15 | 102.20 | 577.08 | 1 684.23 |
| Other financial expenses | -12.71 | -5.64 | -3.12 | -4.96 | -6.59 |
| Reduction non-current investment assets | 1 064.54 | ||||
| Net income from associates (fin.) | 1 041.89 | 404.10 | 400.00 | 17 039.04 | |
| Pre-tax profit | 1 010.04 | - 586.87 | 479.71 | 17 598.26 | 1 624.00 |
| Income taxes | -6.09 | - 109.96 | - 363.86 | ||
| Net earnings | 1 010.04 | - 592.95 | 479.71 | 17 488.30 | 1 260.14 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 1 841.89 | 777.35 | 777.35 | ||
| Investments total | 1 841.89 | 777.35 | 777.35 | ||
| Non-current loans receivable | 4 461.00 | 4 461.00 | |||
| Long term receivables total | 4 461.00 | 4 461.00 | |||
| Inventories total | |||||
| Current owed by particip. interest comp. | 0.98 | 0.98 | 0.98 | ||
| Current other receivables | 13.14 | ||||
| Current deferred tax assets | 13.08 | 11.77 | |||
| Short term receivables total | 0.98 | 0.98 | 14.05 | 13.14 | 11.77 |
| Other current investments | 1 114.65 | 443.08 | 2 022.05 | 10 550.20 | |
| Cash and bank deposits | 898.14 | 142.37 | 1 136.38 | 12 472.99 | 4 468.55 |
| Cash and cash equivalents | 898.14 | 1 257.02 | 1 579.46 | 14 495.04 | 15 018.75 |
| Balance sheet total (assets) | 2 741.01 | 2 035.35 | 2 370.87 | 18 969.17 | 19 491.52 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 113.00 | 113.00 | 1 000.00 | 1 000.00 | 1 000.00 |
| Retained earnings | 1 493.98 | 2 391.01 | 798.06 | 277.77 | 16 766.07 |
| Profit of the financial year | 1 010.04 | - 592.95 | 479.71 | 17 488.30 | 1 260.14 |
| Shareholders equity total | 2 697.01 | 1 991.06 | 2 357.77 | 18 846.07 | 19 106.22 |
| Non-current liabilities total | |||||
| Current trade creditors | 13.10 | 13.10 | 13.10 | 13.10 | 25.00 |
| Current owed to participating | 30.90 | 31.19 | |||
| Short-term deferred tax liabilities | 110.00 | 360.00 | |||
| Other non-interest bearing current liabilities | 0.30 | ||||
| Current liabilities total | 44.00 | 44.29 | 13.10 | 123.10 | 385.30 |
| Balance sheet total (liabilities) | 2 741.01 | 2 035.35 | 2 370.87 | 18 969.17 | 19 491.52 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.